GYRE THERAPEUTICS, INC. ($GYRE)
Filing Information
| Accession Number | 0001140361-26-022235 |
|---|---|
| Form Type | 4 |
| Filing Date | May 20, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
27,960
Total Value
$66,408.40
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Common Stock | โ | May 18, 2026 | Exercise/Conversion | 200 | $0.75 | $150.00 | 700,200 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | May 18, 2026 | Sale | 200 | $6.62 | $1,324.00 | 700,000 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | May 19, 2026 | Exercise/Conversion | 9,120 | $0.75 | $6,840.00 | 709,120 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | May 19, 2026 | Sale | 9,120 | $6.37 | $58,094.40 | 700,000 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (Right to Buy) | Derivative | May 18, 2026 | Exercise/Conversion | 200 | $0.00 | $0.00 | 936,235 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (Right to Buy) | Derivative | May 19, 2026 | Exercise/Conversion | 9,120 | $0.00 | $0.00 | 927,115 | Direct | โ | View Details |